The rationale for buybacks is to improve earnings per share (EPS). That goal is only meaningful to the extent that a company can sustain its profitability. In our current environment how many do ?
Even with companies having an unassailable market position with essential products and services, buybacks send 2 signals to shareholders : a) we have excess cash which we have decided NOT to share directly with you in the form of dividends ( because your BoD knows better than you the shareholder how to use these funds.) b) we think that of all the uses of cash we can make , buying our own shares is the best approach ( if that is not arrogant and self-centered what is it ?)
The truth is that buybacks are really a protective mechanism to put a floor on a plummeting share price. It seldom does. If that is the case, why do companies do it ? More importantly, because it is paramount to manipulating a stock's price ,why is it legal to do ??
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [View article]
Iknowjack, you don't seem to understand what those who have used (not just read some useless studies) Vytorin are telling you. It simply works better than statins while lowering HDL/LDL ratio very successfully.
Now you know where to stick all these charlatanic studies you have been reading !!!
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [View article]
If CNBC’s Pharmaceutical Reporter focused less on misguided study or census findings and more on patient/doctor insights he would do himself and his audience a great service.
He must be in that ignorant minority who believe that those who are on Vytorin will switch out to other medications because of a botched –up panel discussion !! All the doctors I spoke with are amazed at the media coverage of an isolated and ill-conceived study whose findings, delivered as a monologue, defied all scientific conventions of an interactive panel discussion. As a patient who has tried everything over the last 25 years, I know that Zetia delivers amazing LDL lowering effects and that for patients who need a statin along with Zetia (and there are plenty apparently), nothing beats Vytorin in convenience and economics. It is about time we start reporting facts and not survey resullts of projected intentions bordering on fiction.
Don't Buy Into Share Buybacks [View article]
Even with companies having an unassailable market position with essential products and services, buybacks send 2 signals to shareholders :
a) we have excess cash which we have decided NOT to share directly with you in the form of dividends ( because your BoD knows better than you the shareholder how to use these funds.)
b) we think that of all the uses of cash we can make , buying our own shares is the best approach ( if that is not arrogant and self-centered what is it ?)
The truth is that buybacks are really a protective mechanism to put a floor on a plummeting share price. It seldom does. If that is the case, why do companies do it ? More importantly, because it is paramount to manipulating a stock's price ,why is it legal to do ??
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [View article]
Now you know where to stick all these charlatanic studies you have been reading !!!
Merck and SGP's Vytorin/Zetia: Are Doctors Writing Fewer Scripts? [View article]
He must be in that ignorant minority who believe that those who are on Vytorin will switch out to other medications because of a botched –up panel discussion !! All the doctors I spoke with are amazed at the media coverage of an isolated and ill-conceived study whose findings, delivered as a monologue, defied all scientific conventions of an interactive panel discussion. As a patient who has tried everything over the last 25 years, I know that Zetia delivers amazing LDL lowering effects and that for patients who need a statin along with Zetia (and there are plenty apparently), nothing beats Vytorin in convenience and economics.
It is about time we start reporting facts and not survey resullts of projected intentions bordering on fiction.